Global Blood Testing
Global Blood Testing

Blood Testing Comprehensive Study by Type (Instruments, Reagents and Testing Kits, Others), Application (Laboratory, Hospitals, Point of Care (POC) Testing, Blood Banks, Others), Test Types (Complete Blood Count (CBC) (Platelets, Hemoglobin, Hematocrit, Others), Chemistry Tests (Blood Glucose, Calcium, Electrolytes, Kidneys), Enzyme Tests (Troponin, Creatine Kinase), Blood Tests to Assess Heart Disease Risk, Blood Clotting Tests), Methods (Manual, Automated) Players and Region - Global Market Outlook to 2024

Blood Testing Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

May 2019 Edition 228 Pages 215 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Blood Testing Market Scope
Blood tests are very common, blood tests are recommended to see how the body is working. During a blood test, a small sample of blood is taken from the body. It is generally drawn from a vein in arm using a needle or by using a finger prick. The procedure is fast and easy, though it may cause some short-term discomfort. The workers of laboratory draw the blood and analyze it. They use either whole blood to count blood cells or separate the blood cells from the fluid that contains them. This fluid is known as plasma or serum.

The market study is being classified by Type (Instruments, Reagents and Testing Kits and Others), by Application (Laboratory, Hospitals, Point of Care (POC) Testing, Blood Banks and Others) and major geographies with country level break-up.

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Blood Testing market throughout the predicted period.

Abbott Laboratories (United States), Bio-Rad Laboratories Inc. (United States), Roche Holding AG (Switzerland), Quest Diagnostics (United States), Siemens Healthcare (Germany), Danaher (United States), Becton Dickinson & Company (United States), Trinity Biotech PLC (Ireland), Baxter International (United States), Novartis Diagnostics (Switzerland) and Cepheid Corporation (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Meridian Bioscience (United States) and BioMerieux S.A. (France).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Blood Testing market by Type, Application and Region.

On the basis of geography, the market of Blood Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Test Types, the sub-segment i.e. Complete Blood Count (CBC) [Platelets, Hemoglobin, Hematocrit, Others] will boost the Blood Testing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Methods, the sub-segment i.e. Manual will boost the Blood Testing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
On May 14, 2019 Abbott has announced that it has partnered with the National Institutes of Health (NIH) on the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) initiative to accelerate advancements in neuroscience research. Abbott will provide the company's neuromodulation technologies. and On February 25, 2019 Roche and Spark Therapeutics, Inc. has announced that they have entered into a definitive merger agreement for Roche to fully acquire Spark Therapeutics, a leader in discovering, developing and delivering gene therapies with one commercial asset and four programmes currently in clinical trials.
On March 26, 2019 Becton, Dickinson and Company, a leading global medical technology company has announced the CE-IVD certification for the BD FACSDuet automated flow cytometry system, which enables clinical laboratories to improve their efficiency by reducing errors and limiting the manual user interactions required to run assays on the BD FACSLyric clinical flow cytometer.


Market Trend
  • Increasing Preference for Minimally Invasive Diagnostic Procedures
  • Surge in Blood Donations and Organ Offerings

Market Drivers
  • Growing Occurrence of Type I As Well As Type II Diabetes
  • Rise in Prevalence of Infectious Diseases

Opportunities
  • Rise in Awareness about the Safety of Donated Blood
  • Increase in Awareness among Patients about Self-Testing Products
  • Constant Introduction of Movable Home Healthcare Blood Testing Kits

Restraints
  • Increasing Cost of Blood Testing

Challenges
  • The Process Can Be Uncomfortable
  • Testing Is Not Always Definitive


Key Target Audience
Manufacturers of Blood Testing Kits, Suppliers of Blood Testing Kits, Wholesalers, Distributors and Retailers of Blood Testing Kits, Healthcare Industry, Research Organizations and Governmental Bodies

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Instruments
  • Reagents and Testing Kits
  • Others
By Application
  • Laboratory
  • Hospitals
  • Point of Care (POC) Testing
  • Blood Banks
  • Others
By Test Types
  • Complete Blood Count (CBC) [Platelets, Hemoglobin, Hematocrit, Others]
  • Chemistry Tests [Blood Glucose, Calcium, Electrolytes, Kidneys]
  • Enzyme Tests [Troponin, Creatine Kinase]
  • Blood Tests to Assess Heart Disease Risk
  • Blood Clotting Tests

By Methods
  • Manual
  • Automated

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Occurrence of Type I As Well As Type II Diabetes
      • 3.2.2. Rise in Prevalence of Infectious Diseases
    • 3.3. Market Challenges
      • 3.3.1. The Process Can Be Uncomfortable
      • 3.3.2. Testing Is Not Always Definitive
    • 3.4. Market Trends
      • 3.4.1. Increasing Preference for Minimally Invasive Diagnostic Procedures
      • 3.4.2. Surge in Blood Donations and Organ Offerings
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blood Testing, by Type, Application, Test Types, Methods and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Blood Testing (Value)
      • 5.2.1. Global Blood Testing by: Type (Value)
        • 5.2.1.1. Instruments
        • 5.2.1.2. Reagents and Testing Kits
        • 5.2.1.3. Others
      • 5.2.2. Global Blood Testing by: Application (Value)
        • 5.2.2.1. Laboratory
        • 5.2.2.2. Hospitals
        • 5.2.2.3. Point of Care (POC) Testing
        • 5.2.2.4. Blood Banks
        • 5.2.2.5. Others
      • 5.2.3. Global Blood Testing by: Test Types (Value)
        • 5.2.3.1. Complete Blood Count (CBC) [Platelets, Hemoglobin, Hematocrit, Others]
        • 5.2.3.2. Chemistry Tests [Blood Glucose, Calcium, Electrolytes, Kidneys]
        • 5.2.3.3. Enzyme Tests [Troponin, Creatine Kinase]
        • 5.2.3.4. Blood Tests to Assess Heart Disease Risk
        • 5.2.3.5. Blood Clotting Tests
      • 5.2.4. Global Blood Testing by: Methods (Value)
        • 5.2.4.1. Manual
        • 5.2.4.2. Automated
      • 5.2.5. Global Blood Testing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Blood Testing (Price)
      • 5.3.1. Global Blood Testing by: Type (Price)
  • 6. Blood Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bio-Rad Laboratories Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Roche Holding AG (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Quest Diagnostics (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Siemens Healthcare (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Danaher (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Becton Dickinson & Company (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Trinity Biotech PLC (Ireland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Baxter International (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Novartis Diagnostics (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Cepheid Corporation (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Blood Testing Sale, by Type, Application, Test Types, Methods and Region (value and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Blood Testing (Value)
      • 7.2.1. Global Blood Testing by: Type (Value)
        • 7.2.1.1. Instruments
        • 7.2.1.2. Reagents and Testing Kits
        • 7.2.1.3. Others
      • 7.2.2. Global Blood Testing by: Application (Value)
        • 7.2.2.1. Laboratory
        • 7.2.2.2. Hospitals
        • 7.2.2.3. Point of Care (POC) Testing
        • 7.2.2.4. Blood Banks
        • 7.2.2.5. Others
      • 7.2.3. Global Blood Testing by: Test Types (Value)
        • 7.2.3.1. Complete Blood Count (CBC) [Platelets, Hemoglobin, Hematocrit, Others]
        • 7.2.3.2. Chemistry Tests [Blood Glucose, Calcium, Electrolytes, Kidneys]
        • 7.2.3.3. Enzyme Tests [Troponin, Creatine Kinase]
        • 7.2.3.4. Blood Tests to Assess Heart Disease Risk
        • 7.2.3.5. Blood Clotting Tests
      • 7.2.4. Global Blood Testing by: Methods (Value)
        • 7.2.4.1. Manual
        • 7.2.4.2. Automated
      • 7.2.5. Global Blood Testing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Blood Testing (Price)
      • 7.3.1. Global Blood Testing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blood Testing: by Type(USD Million)
  • Table 2. Blood Testing Instruments , by Region USD Million (2013-2018)
  • Table 3. Blood Testing Reagents and Testing Kits , by Region USD Million (2013-2018)
  • Table 4. Blood Testing Others , by Region USD Million (2013-2018)
  • Table 5. Blood Testing: by Application(USD Million)
  • Table 6. Blood Testing Laboratory , by Region USD Million (2013-2018)
  • Table 7. Blood Testing Hospitals , by Region USD Million (2013-2018)
  • Table 8. Blood Testing Point of Care (POC) Testing , by Region USD Million (2013-2018)
  • Table 9. Blood Testing Blood Banks , by Region USD Million (2013-2018)
  • Table 10. Blood Testing Others , by Region USD Million (2013-2018)
  • Table 11. Blood Testing: by Test Types(USD Million)
  • Table 12. Blood Testing Complete Blood Count (CBC) [Platelets, Hemoglobin, Hematocrit, Others] , by Region USD Million (2013-2018)
  • Table 13. Blood Testing Chemistry Tests [Blood Glucose, Calcium, Electrolytes, Kidneys] , by Region USD Million (2013-2018)
  • Table 14. Blood Testing Enzyme Tests [Troponin, Creatine Kinase] , by Region USD Million (2013-2018)
  • Table 15. Blood Testing Blood Tests to Assess Heart Disease Risk , by Region USD Million (2013-2018)
  • Table 16. Blood Testing Blood Clotting Tests , by Region USD Million (2013-2018)
  • Table 17. Blood Testing: by Methods(USD Million)
  • Table 18. Blood Testing Manual , by Region USD Million (2013-2018)
  • Table 19. Blood Testing Automated , by Region USD Million (2013-2018)
  • Table 20. South America Blood Testing, by Country USD Million (2013-2018)
  • Table 21. South America Blood Testing, by Type USD Million (2013-2018)
  • Table 22. South America Blood Testing, by Application USD Million (2013-2018)
  • Table 23. South America Blood Testing, by Test Types USD Million (2013-2018)
  • Table 24. South America Blood Testing, by Methods USD Million (2013-2018)
  • Table 25. Brazil Blood Testing, by Type USD Million (2013-2018)
  • Table 26. Brazil Blood Testing, by Application USD Million (2013-2018)
  • Table 27. Brazil Blood Testing, by Test Types USD Million (2013-2018)
  • Table 28. Brazil Blood Testing, by Methods USD Million (2013-2018)
  • Table 29. Argentina Blood Testing, by Type USD Million (2013-2018)
  • Table 30. Argentina Blood Testing, by Application USD Million (2013-2018)
  • Table 31. Argentina Blood Testing, by Test Types USD Million (2013-2018)
  • Table 32. Argentina Blood Testing, by Methods USD Million (2013-2018)
  • Table 33. Rest of South America Blood Testing, by Type USD Million (2013-2018)
  • Table 34. Rest of South America Blood Testing, by Application USD Million (2013-2018)
  • Table 35. Rest of South America Blood Testing, by Test Types USD Million (2013-2018)
  • Table 36. Rest of South America Blood Testing, by Methods USD Million (2013-2018)
  • Table 37. Asia Pacific Blood Testing, by Country USD Million (2013-2018)
  • Table 38. Asia Pacific Blood Testing, by Type USD Million (2013-2018)
  • Table 39. Asia Pacific Blood Testing, by Application USD Million (2013-2018)
  • Table 40. Asia Pacific Blood Testing, by Test Types USD Million (2013-2018)
  • Table 41. Asia Pacific Blood Testing, by Methods USD Million (2013-2018)
  • Table 42. China Blood Testing, by Type USD Million (2013-2018)
  • Table 43. China Blood Testing, by Application USD Million (2013-2018)
  • Table 44. China Blood Testing, by Test Types USD Million (2013-2018)
  • Table 45. China Blood Testing, by Methods USD Million (2013-2018)
  • Table 46. Japan Blood Testing, by Type USD Million (2013-2018)
  • Table 47. Japan Blood Testing, by Application USD Million (2013-2018)
  • Table 48. Japan Blood Testing, by Test Types USD Million (2013-2018)
  • Table 49. Japan Blood Testing, by Methods USD Million (2013-2018)
  • Table 50. India Blood Testing, by Type USD Million (2013-2018)
  • Table 51. India Blood Testing, by Application USD Million (2013-2018)
  • Table 52. India Blood Testing, by Test Types USD Million (2013-2018)
  • Table 53. India Blood Testing, by Methods USD Million (2013-2018)
  • Table 54. South Korea Blood Testing, by Type USD Million (2013-2018)
  • Table 55. South Korea Blood Testing, by Application USD Million (2013-2018)
  • Table 56. South Korea Blood Testing, by Test Types USD Million (2013-2018)
  • Table 57. South Korea Blood Testing, by Methods USD Million (2013-2018)
  • Table 58. Taiwan Blood Testing, by Type USD Million (2013-2018)
  • Table 59. Taiwan Blood Testing, by Application USD Million (2013-2018)
  • Table 60. Taiwan Blood Testing, by Test Types USD Million (2013-2018)
  • Table 61. Taiwan Blood Testing, by Methods USD Million (2013-2018)
  • Table 62. Australia Blood Testing, by Type USD Million (2013-2018)
  • Table 63. Australia Blood Testing, by Application USD Million (2013-2018)
  • Table 64. Australia Blood Testing, by Test Types USD Million (2013-2018)
  • Table 65. Australia Blood Testing, by Methods USD Million (2013-2018)
  • Table 66. Rest of Asia-Pacific Blood Testing, by Type USD Million (2013-2018)
  • Table 67. Rest of Asia-Pacific Blood Testing, by Application USD Million (2013-2018)
  • Table 68. Rest of Asia-Pacific Blood Testing, by Test Types USD Million (2013-2018)
  • Table 69. Rest of Asia-Pacific Blood Testing, by Methods USD Million (2013-2018)
  • Table 70. Europe Blood Testing, by Country USD Million (2013-2018)
  • Table 71. Europe Blood Testing, by Type USD Million (2013-2018)
  • Table 72. Europe Blood Testing, by Application USD Million (2013-2018)
  • Table 73. Europe Blood Testing, by Test Types USD Million (2013-2018)
  • Table 74. Europe Blood Testing, by Methods USD Million (2013-2018)
  • Table 75. Germany Blood Testing, by Type USD Million (2013-2018)
  • Table 76. Germany Blood Testing, by Application USD Million (2013-2018)
  • Table 77. Germany Blood Testing, by Test Types USD Million (2013-2018)
  • Table 78. Germany Blood Testing, by Methods USD Million (2013-2018)
  • Table 79. France Blood Testing, by Type USD Million (2013-2018)
  • Table 80. France Blood Testing, by Application USD Million (2013-2018)
  • Table 81. France Blood Testing, by Test Types USD Million (2013-2018)
  • Table 82. France Blood Testing, by Methods USD Million (2013-2018)
  • Table 83. Italy Blood Testing, by Type USD Million (2013-2018)
  • Table 84. Italy Blood Testing, by Application USD Million (2013-2018)
  • Table 85. Italy Blood Testing, by Test Types USD Million (2013-2018)
  • Table 86. Italy Blood Testing, by Methods USD Million (2013-2018)
  • Table 87. United Kingdom Blood Testing, by Type USD Million (2013-2018)
  • Table 88. United Kingdom Blood Testing, by Application USD Million (2013-2018)
  • Table 89. United Kingdom Blood Testing, by Test Types USD Million (2013-2018)
  • Table 90. United Kingdom Blood Testing, by Methods USD Million (2013-2018)
  • Table 91. Netherlands Blood Testing, by Type USD Million (2013-2018)
  • Table 92. Netherlands Blood Testing, by Application USD Million (2013-2018)
  • Table 93. Netherlands Blood Testing, by Test Types USD Million (2013-2018)
  • Table 94. Netherlands Blood Testing, by Methods USD Million (2013-2018)
  • Table 95. Rest of Europe Blood Testing, by Type USD Million (2013-2018)
  • Table 96. Rest of Europe Blood Testing, by Application USD Million (2013-2018)
  • Table 97. Rest of Europe Blood Testing, by Test Types USD Million (2013-2018)
  • Table 98. Rest of Europe Blood Testing, by Methods USD Million (2013-2018)
  • Table 99. MEA Blood Testing, by Country USD Million (2013-2018)
  • Table 100. MEA Blood Testing, by Type USD Million (2013-2018)
  • Table 101. MEA Blood Testing, by Application USD Million (2013-2018)
  • Table 102. MEA Blood Testing, by Test Types USD Million (2013-2018)
  • Table 103. MEA Blood Testing, by Methods USD Million (2013-2018)
  • Table 104. Middle East Blood Testing, by Type USD Million (2013-2018)
  • Table 105. Middle East Blood Testing, by Application USD Million (2013-2018)
  • Table 106. Middle East Blood Testing, by Test Types USD Million (2013-2018)
  • Table 107. Middle East Blood Testing, by Methods USD Million (2013-2018)
  • Table 108. Africa Blood Testing, by Type USD Million (2013-2018)
  • Table 109. Africa Blood Testing, by Application USD Million (2013-2018)
  • Table 110. Africa Blood Testing, by Test Types USD Million (2013-2018)
  • Table 111. Africa Blood Testing, by Methods USD Million (2013-2018)
  • Table 112. North America Blood Testing, by Country USD Million (2013-2018)
  • Table 113. North America Blood Testing, by Type USD Million (2013-2018)
  • Table 114. North America Blood Testing, by Application USD Million (2013-2018)
  • Table 115. North America Blood Testing, by Test Types USD Million (2013-2018)
  • Table 116. North America Blood Testing, by Methods USD Million (2013-2018)
  • Table 117. United States Blood Testing, by Type USD Million (2013-2018)
  • Table 118. United States Blood Testing, by Application USD Million (2013-2018)
  • Table 119. United States Blood Testing, by Test Types USD Million (2013-2018)
  • Table 120. United States Blood Testing, by Methods USD Million (2013-2018)
  • Table 121. Canada Blood Testing, by Type USD Million (2013-2018)
  • Table 122. Canada Blood Testing, by Application USD Million (2013-2018)
  • Table 123. Canada Blood Testing, by Test Types USD Million (2013-2018)
  • Table 124. Canada Blood Testing, by Methods USD Million (2013-2018)
  • Table 125. Mexico Blood Testing, by Type USD Million (2013-2018)
  • Table 126. Mexico Blood Testing, by Application USD Million (2013-2018)
  • Table 127. Mexico Blood Testing, by Test Types USD Million (2013-2018)
  • Table 128. Mexico Blood Testing, by Methods USD Million (2013-2018)
  • Table 129. Blood Testing: by Type(USD/Units)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Blood Testing: by Type(USD Million)
  • Table 142. Blood Testing Instruments , by Region USD Million (2019-2024)
  • Table 143. Blood Testing Reagents and Testing Kits , by Region USD Million (2019-2024)
  • Table 144. Blood Testing Others , by Region USD Million (2019-2024)
  • Table 145. Blood Testing: by Application(USD Million)
  • Table 146. Blood Testing Laboratory , by Region USD Million (2019-2024)
  • Table 147. Blood Testing Hospitals , by Region USD Million (2019-2024)
  • Table 148. Blood Testing Point of Care (POC) Testing , by Region USD Million (2019-2024)
  • Table 149. Blood Testing Blood Banks , by Region USD Million (2019-2024)
  • Table 150. Blood Testing Others , by Region USD Million (2019-2024)
  • Table 151. Blood Testing: by Test Types(USD Million)
  • Table 152. Blood Testing Complete Blood Count (CBC) [Platelets, Hemoglobin, Hematocrit, Others] , by Region USD Million (2019-2024)
  • Table 153. Blood Testing Chemistry Tests [Blood Glucose, Calcium, Electrolytes, Kidneys] , by Region USD Million (2019-2024)
  • Table 154. Blood Testing Enzyme Tests [Troponin, Creatine Kinase] , by Region USD Million (2019-2024)
  • Table 155. Blood Testing Blood Tests to Assess Heart Disease Risk , by Region USD Million (2019-2024)
  • Table 156. Blood Testing Blood Clotting Tests , by Region USD Million (2019-2024)
  • Table 157. Blood Testing: by Methods(USD Million)
  • Table 158. Blood Testing Manual , by Region USD Million (2019-2024)
  • Table 159. Blood Testing Automated , by Region USD Million (2019-2024)
  • Table 160. South America Blood Testing, by Country USD Million (2019-2024)
  • Table 161. South America Blood Testing, by Type USD Million (2019-2024)
  • Table 162. South America Blood Testing, by Application USD Million (2019-2024)
  • Table 163. South America Blood Testing, by Test Types USD Million (2019-2024)
  • Table 164. South America Blood Testing, by Methods USD Million (2019-2024)
  • Table 165. Brazil Blood Testing, by Type USD Million (2019-2024)
  • Table 166. Brazil Blood Testing, by Application USD Million (2019-2024)
  • Table 167. Brazil Blood Testing, by Test Types USD Million (2019-2024)
  • Table 168. Brazil Blood Testing, by Methods USD Million (2019-2024)
  • Table 169. Argentina Blood Testing, by Type USD Million (2019-2024)
  • Table 170. Argentina Blood Testing, by Application USD Million (2019-2024)
  • Table 171. Argentina Blood Testing, by Test Types USD Million (2019-2024)
  • Table 172. Argentina Blood Testing, by Methods USD Million (2019-2024)
  • Table 173. Rest of South America Blood Testing, by Type USD Million (2019-2024)
  • Table 174. Rest of South America Blood Testing, by Application USD Million (2019-2024)
  • Table 175. Rest of South America Blood Testing, by Test Types USD Million (2019-2024)
  • Table 176. Rest of South America Blood Testing, by Methods USD Million (2019-2024)
  • Table 177. Asia Pacific Blood Testing, by Country USD Million (2019-2024)
  • Table 178. Asia Pacific Blood Testing, by Type USD Million (2019-2024)
  • Table 179. Asia Pacific Blood Testing, by Application USD Million (2019-2024)
  • Table 180. Asia Pacific Blood Testing, by Test Types USD Million (2019-2024)
  • Table 181. Asia Pacific Blood Testing, by Methods USD Million (2019-2024)
  • Table 182. China Blood Testing, by Type USD Million (2019-2024)
  • Table 183. China Blood Testing, by Application USD Million (2019-2024)
  • Table 184. China Blood Testing, by Test Types USD Million (2019-2024)
  • Table 185. China Blood Testing, by Methods USD Million (2019-2024)
  • Table 186. Japan Blood Testing, by Type USD Million (2019-2024)
  • Table 187. Japan Blood Testing, by Application USD Million (2019-2024)
  • Table 188. Japan Blood Testing, by Test Types USD Million (2019-2024)
  • Table 189. Japan Blood Testing, by Methods USD Million (2019-2024)
  • Table 190. India Blood Testing, by Type USD Million (2019-2024)
  • Table 191. India Blood Testing, by Application USD Million (2019-2024)
  • Table 192. India Blood Testing, by Test Types USD Million (2019-2024)
  • Table 193. India Blood Testing, by Methods USD Million (2019-2024)
  • Table 194. South Korea Blood Testing, by Type USD Million (2019-2024)
  • Table 195. South Korea Blood Testing, by Application USD Million (2019-2024)
  • Table 196. South Korea Blood Testing, by Test Types USD Million (2019-2024)
  • Table 197. South Korea Blood Testing, by Methods USD Million (2019-2024)
  • Table 198. Taiwan Blood Testing, by Type USD Million (2019-2024)
  • Table 199. Taiwan Blood Testing, by Application USD Million (2019-2024)
  • Table 200. Taiwan Blood Testing, by Test Types USD Million (2019-2024)
  • Table 201. Taiwan Blood Testing, by Methods USD Million (2019-2024)
  • Table 202. Australia Blood Testing, by Type USD Million (2019-2024)
  • Table 203. Australia Blood Testing, by Application USD Million (2019-2024)
  • Table 204. Australia Blood Testing, by Test Types USD Million (2019-2024)
  • Table 205. Australia Blood Testing, by Methods USD Million (2019-2024)
  • Table 206. Rest of Asia-Pacific Blood Testing, by Type USD Million (2019-2024)
  • Table 207. Rest of Asia-Pacific Blood Testing, by Application USD Million (2019-2024)
  • Table 208. Rest of Asia-Pacific Blood Testing, by Test Types USD Million (2019-2024)
  • Table 209. Rest of Asia-Pacific Blood Testing, by Methods USD Million (2019-2024)
  • Table 210. Europe Blood Testing, by Country USD Million (2019-2024)
  • Table 211. Europe Blood Testing, by Type USD Million (2019-2024)
  • Table 212. Europe Blood Testing, by Application USD Million (2019-2024)
  • Table 213. Europe Blood Testing, by Test Types USD Million (2019-2024)
  • Table 214. Europe Blood Testing, by Methods USD Million (2019-2024)
  • Table 215. Germany Blood Testing, by Type USD Million (2019-2024)
  • Table 216. Germany Blood Testing, by Application USD Million (2019-2024)
  • Table 217. Germany Blood Testing, by Test Types USD Million (2019-2024)
  • Table 218. Germany Blood Testing, by Methods USD Million (2019-2024)
  • Table 219. France Blood Testing, by Type USD Million (2019-2024)
  • Table 220. France Blood Testing, by Application USD Million (2019-2024)
  • Table 221. France Blood Testing, by Test Types USD Million (2019-2024)
  • Table 222. France Blood Testing, by Methods USD Million (2019-2024)
  • Table 223. Italy Blood Testing, by Type USD Million (2019-2024)
  • Table 224. Italy Blood Testing, by Application USD Million (2019-2024)
  • Table 225. Italy Blood Testing, by Test Types USD Million (2019-2024)
  • Table 226. Italy Blood Testing, by Methods USD Million (2019-2024)
  • Table 227. United Kingdom Blood Testing, by Type USD Million (2019-2024)
  • Table 228. United Kingdom Blood Testing, by Application USD Million (2019-2024)
  • Table 229. United Kingdom Blood Testing, by Test Types USD Million (2019-2024)
  • Table 230. United Kingdom Blood Testing, by Methods USD Million (2019-2024)
  • Table 231. Netherlands Blood Testing, by Type USD Million (2019-2024)
  • Table 232. Netherlands Blood Testing, by Application USD Million (2019-2024)
  • Table 233. Netherlands Blood Testing, by Test Types USD Million (2019-2024)
  • Table 234. Netherlands Blood Testing, by Methods USD Million (2019-2024)
  • Table 235. Rest of Europe Blood Testing, by Type USD Million (2019-2024)
  • Table 236. Rest of Europe Blood Testing, by Application USD Million (2019-2024)
  • Table 237. Rest of Europe Blood Testing, by Test Types USD Million (2019-2024)
  • Table 238. Rest of Europe Blood Testing, by Methods USD Million (2019-2024)
  • Table 239. MEA Blood Testing, by Country USD Million (2019-2024)
  • Table 240. MEA Blood Testing, by Type USD Million (2019-2024)
  • Table 241. MEA Blood Testing, by Application USD Million (2019-2024)
  • Table 242. MEA Blood Testing, by Test Types USD Million (2019-2024)
  • Table 243. MEA Blood Testing, by Methods USD Million (2019-2024)
  • Table 244. Middle East Blood Testing, by Type USD Million (2019-2024)
  • Table 245. Middle East Blood Testing, by Application USD Million (2019-2024)
  • Table 246. Middle East Blood Testing, by Test Types USD Million (2019-2024)
  • Table 247. Middle East Blood Testing, by Methods USD Million (2019-2024)
  • Table 248. Africa Blood Testing, by Type USD Million (2019-2024)
  • Table 249. Africa Blood Testing, by Application USD Million (2019-2024)
  • Table 250. Africa Blood Testing, by Test Types USD Million (2019-2024)
  • Table 251. Africa Blood Testing, by Methods USD Million (2019-2024)
  • Table 252. North America Blood Testing, by Country USD Million (2019-2024)
  • Table 253. North America Blood Testing, by Type USD Million (2019-2024)
  • Table 254. North America Blood Testing, by Application USD Million (2019-2024)
  • Table 255. North America Blood Testing, by Test Types USD Million (2019-2024)
  • Table 256. North America Blood Testing, by Methods USD Million (2019-2024)
  • Table 257. United States Blood Testing, by Type USD Million (2019-2024)
  • Table 258. United States Blood Testing, by Application USD Million (2019-2024)
  • Table 259. United States Blood Testing, by Test Types USD Million (2019-2024)
  • Table 260. United States Blood Testing, by Methods USD Million (2019-2024)
  • Table 261. Canada Blood Testing, by Type USD Million (2019-2024)
  • Table 262. Canada Blood Testing, by Application USD Million (2019-2024)
  • Table 263. Canada Blood Testing, by Test Types USD Million (2019-2024)
  • Table 264. Canada Blood Testing, by Methods USD Million (2019-2024)
  • Table 265. Mexico Blood Testing, by Type USD Million (2019-2024)
  • Table 266. Mexico Blood Testing, by Application USD Million (2019-2024)
  • Table 267. Mexico Blood Testing, by Test Types USD Million (2019-2024)
  • Table 268. Mexico Blood Testing, by Methods USD Million (2019-2024)
  • Table 269. Blood Testing: by Type(USD/Units)
  • Table 270. Research Programs/Design for This Report
  • Table 271. Key Data Information from Secondary Sources
  • Table 272. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blood Testing: by Type USD Million (2013-2018)
  • Figure 5. Global Blood Testing: by Application USD Million (2013-2018)
  • Figure 6. Global Blood Testing: by Test Types USD Million (2013-2018)
  • Figure 7. Global Blood Testing: by Methods USD Million (2013-2018)
  • Figure 8. South America Blood Testing Share (%), by Country
  • Figure 9. Asia Pacific Blood Testing Share (%), by Country
  • Figure 10. Europe Blood Testing Share (%), by Country
  • Figure 11. MEA Blood Testing Share (%), by Country
  • Figure 12. North America Blood Testing Share (%), by Country
  • Figure 13. Global Blood Testing: by Type USD/Units (2013-2018)
  • Figure 14. Global Blood Testing share by Players 2018 (%)
  • Figure 15. Global Blood Testing share by Players (Top 3) 2018(%)
  • Figure 16. Global Blood Testing share by Players (Top 5) 2018(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 19. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 20. Bio-Rad Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Bio-Rad Laboratories Inc. (United States) Revenue: by Geography 2018
  • Figure 22. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Roche Holding AG (Switzerland) Revenue: by Geography 2018
  • Figure 24. Quest Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 25. Quest Diagnostics (United States) Revenue: by Geography 2018
  • Figure 26. Siemens Healthcare (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Siemens Healthcare (Germany) Revenue: by Geography 2018
  • Figure 28. Danaher (United States) Revenue, Net Income and Gross profit
  • Figure 29. Danaher (United States) Revenue: by Geography 2018
  • Figure 30. Becton Dickinson & Company (United States) Revenue, Net Income and Gross profit
  • Figure 31. Becton Dickinson & Company (United States) Revenue: by Geography 2018
  • Figure 32. Trinity Biotech PLC (Ireland) Revenue, Net Income and Gross profit
  • Figure 33. Trinity Biotech PLC (Ireland) Revenue: by Geography 2018
  • Figure 34. Baxter International (United States) Revenue, Net Income and Gross profit
  • Figure 35. Baxter International (United States) Revenue: by Geography 2018
  • Figure 36. Novartis Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 37. Novartis Diagnostics (Switzerland) Revenue: by Geography 2018
  • Figure 38. Cepheid Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 39. Cepheid Corporation (United States) Revenue: by Geography 2018
  • Figure 40. Global Blood Testing: by Type USD Million (2019-2024)
  • Figure 41. Global Blood Testing: by Application USD Million (2019-2024)
  • Figure 42. Global Blood Testing: by Test Types USD Million (2019-2024)
  • Figure 43. Global Blood Testing: by Methods USD Million (2019-2024)
  • Figure 44. South America Blood Testing Share (%), by Country
  • Figure 45. Asia Pacific Blood Testing Share (%), by Country
  • Figure 46. Europe Blood Testing Share (%), by Country
  • Figure 47. MEA Blood Testing Share (%), by Country
  • Figure 48. North America Blood Testing Share (%), by Country
  • Figure 49. Global Blood Testing: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • Abbott Laboratories (United States)
  • Bio-Rad Laboratories Inc. (United States)
  • Roche Holding AG (Switzerland)
  • Quest Diagnostics (United States)
  • Siemens Healthcare (Germany)
  • Danaher (United States)
  • Becton Dickinson & Company (United States)
  • Trinity Biotech PLC (Ireland)
  • Baxter International (United States)
  • Novartis Diagnostics (Switzerland)
  • Cepheid Corporation (United States)
Additional players considered in the study are as follows:
Meridian Bioscience (United States) , BioMerieux S.A. (France)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation